TD Cowen Reiterates Buy Rating on Protera Therapeutics (TARA)

December 5, 2024 11:08 AM EST Send to a Friend
TD Cowen analyst Stacy Ku reiterated a Buy rating and $50.00 price target on Protera Therapeutics (NASDAQ: TARA)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login